The global intraosseous infusion devices market accounted for USD 0.924 billion in 2023 and is expected to reach USD 1.79 billion by 2034 with a CAGR of 6.24% during the forecast period 2024-2034. The market is expected to expand due to various factors, including the expanding emphasis on out-of-hospital emergency treatment, the increasing recognition and application of intraosseous infusion, technological developments in intraosseous care, and the increasing number of trauma and emergency cases.
Intraosseous access is becoming more and more important in emergency scenarios, as recognized by healthcare specialists. The use of intraosseous infusion devices is highlighted in emergency medical procedures training programs and guidelines as a quick and efficient way to gain vascular access. The use of intraosseous infusion devices is increasing in several healthcare settings, including emergency rooms, critical care units, and pre-hospital care, as a result of this awareness. For instance, Z-Medica, LLC, a well-known producer of hemostatic devices, including intraosseous access solutions, was acquired by Teleflex Incorporated in January 2022.
By product, the manual IO needles segment accounted for the highest revenue-grossing segment in the global intraosseous infusion devices market in 2023 owing to the growing preference for manual IO needles due to their affordability, simplicity, and widespread availability, particularly in resource-limited settings. For instance, in March 2022, PerSys Medical introduced a new intraosseous device, the Bone Injection GunTM (B.I.G.TM) 45, which offers enhanced functionality and user-friendliness. Additionally, the B.I.G. segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for devices offering automated insertion systems, advanced safety features, and enhanced user experience, particularly in advanced healthcare settings.
By route of administration, the distal tibia segment accounted for the highest revenue-grossing segment in the global intraosseous infusion devices market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the growing recognition of the distal tibia's accessibility, safety, and effectiveness as a preferred site for intraosseous access, especially in emergency medical procedures. For instance, Biopsybell S.r.l. announced in January 2022 the release of a new intraosseous infusion device that has better usage and safety characteristics.
By technology, the manual devices segment accounted for the highest revenue-grossing segment in the global intraosseous infusion devices market in 2023 owing to the increasing demand for affordable and easy-to-use manual devices, particularly in resource-constrained healthcare settings. For instance, in March 2022, Aero Healthcare bolstered its position in the emergency medical equipment market by adding a unique intraosseous access device to its portfolio. Additionally, the automatic and powered devices segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of automated and powered devices due to their ability to offer rapid and precise insertion, enhanced user experience, and reduced risk of operator error.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global intraosseous infusion devices market in 2023 owing to the increasing adoption of intraosseous infusion devices in hospital and clinic settings for emergency medical procedures and critical care management. For instance, WaisMed Limited and a top medical research institute worked together in February 2022 to create a novel intraosseous infusion technology that aims to improve patient care in emergencies. Additionally, the growing demand for advanced medical treatments and minimally invasive procedures in outpatient settings is expected to propel the adoption of intraosseous infusion devices for critical care and emergency preparedness, and the ambulatory surgical center segment is expected to grow at the fastest CAGR during the forecast period.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high healthcare expenditure, advanced healthcare infrastructure, increasing incidence of trauma cases, and robust adoption of innovative medical technologies in the region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing awareness about emergency medical procedures, rising healthcare spending, and growing emphasis on improving access to critical care services in the region. For instance, Physeon GmbH stated in April 2022 that it was expanding its range of products to include a new intraosseous infusion device specifically meant for juvenile patients.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Intraosseous access is becoming more and more important in emergency scenarios, as recognized by healthcare specialists. The use of intraosseous infusion devices is highlighted in emergency medical procedures training programs and guidelines as a quick and efficient way to gain vascular access. The use of intraosseous infusion devices is increasing in several healthcare settings, including emergency rooms, critical care units, and pre-hospital care, as a result of this awareness. For instance, Z-Medica, LLC, a well-known producer of hemostatic devices, including intraosseous access solutions, was acquired by Teleflex Incorporated in January 2022.
By product, the manual IO needles segment accounted for the highest revenue-grossing segment in the global intraosseous infusion devices market in 2023 owing to the growing preference for manual IO needles due to their affordability, simplicity, and widespread availability, particularly in resource-limited settings. For instance, in March 2022, PerSys Medical introduced a new intraosseous device, the Bone Injection GunTM (B.I.G.TM) 45, which offers enhanced functionality and user-friendliness. Additionally, the B.I.G. segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for devices offering automated insertion systems, advanced safety features, and enhanced user experience, particularly in advanced healthcare settings.
By route of administration, the distal tibia segment accounted for the highest revenue-grossing segment in the global intraosseous infusion devices market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the growing recognition of the distal tibia's accessibility, safety, and effectiveness as a preferred site for intraosseous access, especially in emergency medical procedures. For instance, Biopsybell S.r.l. announced in January 2022 the release of a new intraosseous infusion device that has better usage and safety characteristics.
By technology, the manual devices segment accounted for the highest revenue-grossing segment in the global intraosseous infusion devices market in 2023 owing to the increasing demand for affordable and easy-to-use manual devices, particularly in resource-constrained healthcare settings. For instance, in March 2022, Aero Healthcare bolstered its position in the emergency medical equipment market by adding a unique intraosseous access device to its portfolio. Additionally, the automatic and powered devices segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of automated and powered devices due to their ability to offer rapid and precise insertion, enhanced user experience, and reduced risk of operator error.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global intraosseous infusion devices market in 2023 owing to the increasing adoption of intraosseous infusion devices in hospital and clinic settings for emergency medical procedures and critical care management. For instance, WaisMed Limited and a top medical research institute worked together in February 2022 to create a novel intraosseous infusion technology that aims to improve patient care in emergencies. Additionally, the growing demand for advanced medical treatments and minimally invasive procedures in outpatient settings is expected to propel the adoption of intraosseous infusion devices for critical care and emergency preparedness, and the ambulatory surgical center segment is expected to grow at the fastest CAGR during the forecast period.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high healthcare expenditure, advanced healthcare infrastructure, increasing incidence of trauma cases, and robust adoption of innovative medical technologies in the region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing awareness about emergency medical procedures, rising healthcare spending, and growing emphasis on improving access to critical care services in the region. For instance, Physeon GmbH stated in April 2022 that it was expanding its range of products to include a new intraosseous infusion device specifically meant for juvenile patients.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Route of Administration, Technology, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Intraosseous Infusion Devices Market Report 2023 - 2034
Intraosseous Infusion Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- B.I.G
- FAST1
- EZ-IO
- FASTR
- IO Needles
- Others
Intraosseous Infusion Devices Market Analysis & Forecast by Route of Administration 2023 - 2034 (Revenue USD Bn)
- Sternum
- Distal & Proximal Tibia
- Distal Femur
- Calcaneus
- Head of Humerus
Intraosseous Infusion Devices Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Manual
- Automatic
- Impact Driven
- Power Drill
Intraosseous Infusion Devices Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
Intraosseous Infusion Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Intraosseous Infusion Devices Market: Product Estimates & Trend Analysis
8. Intraosseous Infusion Devices Market: Route of Administration Estimates & Trend Analysis
9. Intraosseous Infusion Devices Market: Technology Estimates & Trend Analysis
10. Intraosseous Infusion Devices Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Intraosseous Infusion Devices Market
13. Europe Global Intraosseous Infusion Devices Market
14. Asia Pacific Global Intraosseous Infusion Devices Market
15. Latin America Global Intraosseous Infusion Devices Market
16. MEA Global Intraosseous Infusion Devices Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Pyng Medical Corporation
- Teleflex Incorporated
- PerSys Medical
- Cook Medical LLC
- Becton
- Dickinson and Company (BD)
- VBM Medizintechnik GmbH
- Biopsybell S.r.l.
- Cook Medical LLC
- Aero Healthcare
- WaisMed Limited
- Arrow International Inc.
- Physeon GmbH
- Vidacare Corporation
- FAST1 LLC
- Teleflex Medical OEM.
